RxDoctor Payments Data

Hany Shehata, MD

Psychiatry · Niagara Falls, NYNPI 1225008402

Payments from drug & device makers

$1,719in general payments, 2019–2025

Across 97 payments — averaging $17.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vanda Pharmaceuticals Inc.$654
  • AbbVie$317
  • Sunovion Pharmaceuticals Inc.$233
  • Takeda Pharmaceuticals U.S.A., Inc.$180
  • Alkermes, Inc.$163
  • Johnson & Johnson$58
  • plus $113 from 4 others

What the payments were for

  • Food & beverage$1,53990%
  • Education$18010%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,719 in reported general payments places this provider in the 80th percentile of 3,713 psychiatry providers in New York.

See all psychiatry providers in New York

Medicare billing

Part B allowed, 2024
$25,523
Medicare patients
66
Services billed
284

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate48$124,073
Abilify MaintenaAripiprazole44$122,107
TrintellixVortioxetine Hydrobromide48$22,814
VraylarCariprazine Hcl15$22,026
FanaptIloperidone16$18,270
Chlorpromazine Hcl42$10,411
Lurasidone Hcl28$10,191
Oxcarbazepine269$9,588
Aripiprazole192$8,390
Quetiapine Fumarate327$8,081
Ambien CrZolpidem Tartrate11$7,313
Mirtazapine340$5,631
Alprazolam425$4,634
Zolpidem Tartrate473$4,595
Divalproex Sodium ErDivalproex Sodium70$3,332

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$58$124,07348 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$51$122,10744 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$180$22,81448 claims
AbbVieVraylar$317$22,02615 claims
Vanda Pharmaceuticals Inc.Fanapt$654$18,27016 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,713 psychiatry providers in New York.

Other psychiatry in Niagara Falls

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →